Top Markets
#1 QuantixAI QuantixAI +102.23%
#2 Pons Pons +31.77%
#3 龙虾 (Lobster) 龙虾 (Lobster) +31.60%
#4 Rain Rain +30.90%
#5 MetaDAO MetaDAO +27.67%
#6 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +24.74%
#7 Bedrock Bedrock +20.57%
#8 Ontology Gas Ontology Gas +18.03%
#9 Prom Prom +18.01%
#10 peaq peaq +16.66%
Coin of the day
QuantixAI QuantixAI
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Sinew Pharma Inc. Sinew Pharma Inc.

Sinew Pharma Inc.

6634
Classement en actions #20256
Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research,... Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research, development, and commercialization of new therapeutics. Its core mission revolves around pioneering innovative solutions for hepatotoxicity-free acetaminophen and addressing various fatty liver conditions. The company's robust pipeline features SNP-610, a drug candidate currently advancing through Phase II clinical trials in Taiwan for the treatment of non-alcoholic steatohepatitis (NASH). Another early-stage compound, SNP-630, is also in preclinical development, targeting NASH. Beyond liver disease, Sinew Pharma is progressing SNP-810 for its analgesic and antipyretic properties. Furthermore, the firm is developing SNP-830 and SNP-840, positioned as liver-safe pain medications specifically for the United States market. Established in 2014, Sinew Pharma Inc. maintains its headquarters in Taipei City, Taiwan.
Prix de l'action
$1.90
Capitalisation boursière
$135.79M
Changement (1 jour)
-0.50%
Changement (1 an)
20.89%
Pays
TW
Échange Sinew Pharma Inc. (6634)

Catégorie

Healthcare
Ratio P/S pour Sinew Pharma Inc. (6634)
Ratio P/S au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Sinew Pharma Inc., le ratio cours/ventes actuel (TTM) est 0. À la fin de 2026, le ratio P/S était de 0.
Historique du ratio P/S pour Sinew Pharma Inc. de 2026 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
Pas assez de données pour les dates fournies.
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH